Adverum Biotechnologies Surpasses Earnings Expectations with GAAP EPS of -$0.23
Monday, 18 March 2024, 20:35
Adverum Biotechnologies GAAP EPS Results
Adverum Biotechnologies has recently released its latest GAAP EPS results, showcasing a positive trend in its financial performance. The company reported a GAAP EPS of -$0.23, outperforming market expectations by $0.11.
Key Highlights:
- Adverum Biotechnologies surpasses earnings estimates with a stronger GAAP EPS of -$0.23
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.